Nanobiotix S.A. (NANO.PA)
EUR 3.0
(-0.17%)
EUR 3.0
(-0.17%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.08 EUR | 34.15% |
| 2022 | -1.64 EUR | -21.48% |
| 2021 | -1.35 EUR | 2.17% |
| 2020 | -1.38 EUR | 41.28% |
| 2019 | -2.35 EUR | -51.61% |
| 2018 | -1.55 EUR | -3.33% |
| 2017 | -1.50 EUR | -4.9% |
| 2016 | -1.43 EUR | -19.17% |
| 2015 | -1.20 EUR | -62.16% |
| 2014 | -0.74 EUR | 2.63% |
| 2013 | -0.76 EUR | -16.92% |
| 2012 | -0.65 EUR | 80.99% |
| 2011 | -3.42 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.46 EUR | 0.0% |
| 2023 FY | - EUR | 34.15% |
| 2023 Q4 | -0.31 EUR | 0.0% |
| 2023 Q2 | -0.80 EUR | 0.0% |
| 2022 Q4 | -0.88 EUR | 0.0% |
| 2022 FY | - EUR | -21.48% |
| 2022 Q2 | -0.76 EUR | 0.0% |
| 2021 Q4 | -0.48 EUR | 0.0% |
| 2021 FY | - EUR | 2.17% |
| 2021 Q2 | -0.88 EUR | 0.0% |
| 2020 Q4 | -0.47 EUR | 0.0% |
| 2020 Q2 | -0.91 EUR | 0.0% |
| 2020 FY | - EUR | 41.28% |
| 2019 Q2 | -1.15 EUR | 0.0% |
| 2019 Q4 | -1.21 EUR | 0.0% |
| 2019 FY | - EUR | -51.61% |
| 2018 Q4 | -0.91 EUR | 0.0% |
| 2018 FY | - EUR | -3.33% |
| 2018 Q2 | -0.64 EUR | 0.0% |
| 2017 Q2 | -0.76 EUR | 0.0% |
| 2017 FY | - EUR | -4.9% |
| 2017 Q4 | -0.74 EUR | 0.0% |
| 2016 FY | - EUR | -19.17% |
| 2016 Q2 | -0.68 EUR | 0.0% |
| 2016 Q4 | -0.75 EUR | 0.0% |
| 2015 Q4 | -0.69 EUR | 0.0% |
| 2015 Q2 | -0.52 EUR | 0.0% |
| 2015 FY | - EUR | -62.16% |
| 2014 Q4 | -0.39 EUR | 0.0% |
| 2014 FY | - EUR | 2.63% |
| 2014 Q2 | -0.35 EUR | 0.0% |
| 2013 Q3 | -0.19 EUR | 52.5% |
| 2013 Q2 | -0.40 EUR | -110.53% |
| 2013 Q1 | -0.19 EUR | 0.0% |
| 2013 FY | - EUR | -16.92% |
| 2013 Q4 | -0.36 EUR | -89.47% |
| 2012 Q3 | -0.16 EUR | 0.0% |
| 2012 Q1 | -0.16 EUR | 0.0% |
| 2012 Q4 | -0.19 EUR | -18.75% |
| 2012 FY | - EUR | 80.99% |
| 2012 Q2 | -0.16 EUR | 0.0% |
| 2011 Q3 | -0.86 EUR | 0.0% |
| 2011 Q2 | -0.86 EUR | 0.0% |
| 2011 Q1 | -0.86 EUR | 0.0% |
| 2011 FY | - EUR | 0.0% |
| 2011 Q4 | -0.16 EUR | 81.4% |
| 2010 Q4 | -0.86 EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -800.0% |
| ABIVAX Société Anonyme | -3.43 EUR | 68.513% |
| Adocia SA | -1.91 EUR | 43.455% |
| Aelis Farma SA | -0.39 EUR | -176.923% |
| Biophytis S.A. | -12.55 EUR | 91.394% |
| Advicenne S.A. | -0.67 EUR | -61.194% |
| genOway Société anonyme | 0.17 EUR | 735.294% |
| IntegraGen SA | -0.03 EUR | -4069.884% |
| Medesis Pharma S.A. | -0.80 EUR | -35.0% |
| Neovacs S.A. | -0.00 EUR | -43100.0% |
| NFL Biosciences SA | -0.46 EUR | -134.783% |
| Plant Advanced Technologies SA | 0.07 EUR | 1642.857% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -1086.813% |
| Sensorion SA | -0.17 EUR | -535.294% |
| Theranexus Société Anonyme | -0.88 EUR | -22.727% |
| TME Pharma N.V. | -1.34 EUR | 19.403% |
| Valbiotis SA | -0.59 EUR | -83.051% |
| TheraVet SA | -0.49 EUR | -120.408% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -620.0% |
| DBV Technologies S.A. | -0.71 EUR | -52.113% |
| Genfit S.A. | -0.58 EUR | -86.207% |
| GeNeuro SA | -0.59 EUR | -83.051% |
| Innate Pharma S.A. | -0.09 EUR | -1047.715% |
| Inventiva S.A. | -2.43 EUR | 55.556% |
| MaaT Pharma SA | -1.73 EUR | 37.572% |
| MedinCell S.A. | -0.88 EUR | -22.727% |
| OSE Immunotherapeutics SA | -1.18 EUR | 8.475% |
| Poxel S.A. | -0.91 EUR | -18.681% |
| GenSight Biologics S.A. | -0.54 EUR | -100.0% |
| Transgene SA | -0.22 EUR | -390.909% |
| Valneva SE | -0.73 EUR | -47.945% |